Branch, TIBS, vol. 23: pp. 45-50, Feb. 1998.* |
Gibbs et al, Cell, vol. 79: pp. 193-198, Oct. 1994.* |
Orkin et al, Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy, published by NIH, unnumbered pages, Dec. 7, 1995.* |
Verma et al, Nature, vol. 389: pp. 239-242, Sep. 18, 1997.* |
Caldwell, Yakubutsu Dotai, vol. 11(1): pp. 119-125, 1996.* |
Krontiris, Molecular and Cellular Biology of Cancer, Chapters 71-72, Internal Medicine, 4th Edition, pp. 699-715, 1995.* |
Gura, Science, vol. 278, pp. 1041-1042, Nov. 7, 1997.* |
Bentires-Alj et al, Cancer Research, vol. 59: pp. 811-815, Feb. 15, 1999.* |
Fox, Nature Biotechnology, vol. 18: pp. 143-144, Feb. 2000.* |
Wang et al.; TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB, Science, 274: 784-787 (Nov. 1, 1996). |
Slater et al., Constitutive nuclear NF κB/rel DNA-binding activity of rat thymocytes is increased by stimuli that promote apoptosis, but not inhibited by pyrrolidine dithocarbamate, Biochem J. 312:833-838 (1995). |
Taglialatela et al.; Inhibition of Nuclear Factor Kappa B (NF κB) Activity Induces Nerve Growth Factor-Resistant Apoptosis in :C12 Cells, J. Neuroscience Research, 47:155-162 (1997). |